Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Markor Chemical is a prominent Chinese chemical manufacturer and a subsidiary of the Markor Investment Group, specializing in the production of high-purity fine chemicals. The company is recognized as a global leader in the production of 1,4-butanediol (BDO) and its derivatives, such as tetrahydrofuran (THF) and gamma-butyrolactone (GBL). These products are essential intermediates and solvents used extensively in the synthesis of pharmaceuticals, as well as in the production of high-performance polymers and textiles. Operating out of large-scale facilities in Xinjiang, Markor Chemical provides critical raw materials to the global life sciences and chemical processing industries. The company is increasingly focusing on sustainable manufacturing practices and the development of bio-based chemical alternatives to support the green transition in the chemical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Markor Chemicals Group.